Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
Jakub Mensik overcame rain and an opponent chasing history when he stunned six-time champi
- KIPG: Son of a vegetable vendor, Bihar’s Jhandu Kumar eyes Worlds, 2028 Paralympics
- Hardik Singh credits hard work and team unity for receiving HI Midfielder of the Year award
- Djokovic, Alcaraz land in same half of Miami draw
- India to host 2nd Asian Yogasana Championships from March 29 to 31
- FA Cup: AFC Bournemouth secure 5-4 penalty shootout win vs Wolves to reach QF
Yogi Adityanath for 'EVM strongroom-like' security for Covid vaccine Last Updated : 07 Dec 2020 05:08:49 PM IST CM Yogi Uttar Pradesh Chief Minister Yogi Adityanath has set up team of senior officers to ensure safety and security Covid vaccine storage centres across the state. Yogi Adityanath has asked for a 'EVM strongroom kind of security' in the storage areas.
He has also directed officials to scale up storage capacity to up to 2.3 lakh litres of the vaccine by December 15.Yogi Adityanath said the cold chain facilities would be arranged at each districts and divisions.He directed officials to ensure that healthcare workers are trained in large numbers to administer the vaccines.Prime Minister Narendra Modi had said on Friday that a COVID-19 vaccine may be ready in a few weeks and asserted that the vaccination drive in India will begin as soon as scientists give the nod.Five vaccine candidates are in different phases of clinical trials in India with the Serum Institute of India conducting phase-three trial of the Oxford-AstraZeneca COVID-19 vaccine.Covaxin, a vaccine indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) has also started its phase-three clinical trial.Another developed in the country by Zydus Cadila, has completed phase-two clinical trial.IANS Lucknow For Latest Updates Please-
Join us on
Follow us on
172.31.16.186